
Fat loss peptides are research compounds that interact with metabolic signaling pathways in the body. These peptides are studied in laboratory settings for their effects on energy expenditure, appetite regulation, glucose metabolism, and body composition.
The most extensively researched fat loss peptides include GLP-1 (Glucagon-Like Peptide-1) receptor agonists, GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor agonists, and mitochondrial-derived peptides. Each class of peptides operates through distinct molecular mechanisms.
Key Research Areas: Metabolic signaling pathways, appetite regulation mechanisms, glucose homeostasis, insulin sensitivity, energy expenditure, adipose tissue metabolism, and mitochondrial function.
Bind to GLP-1 receptors, influencing glucose metabolism, insulin secretion, and appetite signaling pathways.
Examples: Semaglutide
Activate multiple receptors (GIP/GLP-1/Glucagon) for broader metabolic pathway modulation.
Examples: Retatrutide, Tirzepatide
Mitochondrial-derived peptides that influence cellular energy homeostasis and metabolic regulation.
Examples: MOTS-C
| Peptide | Receptor Targets | Primary Research Focus | Half-Life |
|---|---|---|---|
| Retatrutide | GIP/GLP-1/Glucagon | Triple receptor metabolic signaling | ~5-7 days |
| Semaglutide | GLP-1 | Appetite regulation, glucose metabolism | ~7 days |
| Tirzepatide | GIP/GLP-1 | Dual receptor metabolic pathways | ~5 days |
| AOD-9604 | hGH fragment | Lipolysis, fat metabolism | ~2 hours |
| MOTS-C | Mitochondrial signaling | Metabolic regulation, insulin sensitivity | ~2-3 hours |

Mechanism: Triple GIP/GLP-1/Glucagon receptor agonist
Research: Metabolic signaling, energy expenditure, body composition

Mechanism: GLP-1 receptor agonist
Research: Appetite regulation, glucose metabolism, weight management

Mechanism: Dual GIP/GLP-1 receptor agonist
Research: Metabolic pathways, insulin sensitivity, adipose tissue

Mechanism: Modified C-terminal fragment of hGH
Research: Lipolysis, fat metabolism, body composition

Mechanism: Mitochondrial-derived peptide
Research: Metabolic regulation, insulin sensitivity, energy homeostasis
Fat loss peptides are research compounds that interact with metabolic pathways, including GLP-1 receptors, GIP receptors, and mitochondrial signaling. They are studied for their effects on energy expenditure, appetite regulation, and body composition in laboratory settings.
GLP-1 (Glucagon-Like Peptide-1) receptor agonists bind to GLP-1 receptors, influencing glucose metabolism, insulin secretion, and appetite signaling pathways. Research compounds like Semaglutide and Tirzepatide are studied for their metabolic effects.
Retatrutide is a triple agonist (GIP/GLP-1/Glucagon receptors) while Tirzepatide is a dual agonist (GIP/GLP-1 receptors). Retatrutide includes glucagon receptor activation, which may influence energy expenditure pathways differently in research models.
MOTS-C is a mitochondrial-derived peptide encoded in the mitochondrial genome. It is studied for its role in metabolic regulation, insulin sensitivity, and cellular energy homeostasis in laboratory research.